Olema Pharmaceuticals
OLMA
OLMA
91 hedge funds and large institutions have $155M invested in Olema Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-6
Holders Change %
-6.19%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
24
Reduced
34
Closed
21
Calls
$179K
Puts
$351K
Net Calls
-$172K
Net Calls Change
-$1.11M
Top Buyers
| 1 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$11.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$2.39M |
| 3 |
BlackRock
New York
|
+$1.09M |
| 4 |
Renaissance Technologies
New York
|
+$1.05M |
| 5 |
Goldman Sachs
New York
|
+$972K |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$7.64M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$7.01M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.39M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.25M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.11M |
